Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (112)	3/29/1999 11:33:00 AM
From: Mike McFarland	Respond to of 52153

Well we have seen quite a bit of chat from the gurus that the second tier are the ones that will go first...and your list is a great place to start. The ones I have circled right now (but dont own) are CORR, MLNM, INCY, GLFD, and VRTX. But I don't have a very sophisticated way of doing this...it basically comes down to multiple recommendations and appearances on these bio threads, and pretty soon my notes have lots of scrawls next to a handful of symbols (or a manilla folder gets thick with interesting articles I've printed out). In the Weather Service we use this lame method sometimes too--where all the lines cross, that's where the storms will be;-) I guess some of these are really value plays instead of takeover plays (incy), I don't worry too much about the distinction, I just want to buy stuff cheap. I'd like to see what the thoughts lately are on NBIX...for the moment that looks the cheapest of anything, but I have not read the thread--you had it at trading cash/share at 63%...only beat out by BTRN right? (axph also at 63%, mbio ignored new numbers after the merger with gmed). The thing that gets me...is even when a stock gets pretty good discussion (like btrn has lately on these bio threads) it still does not move. You would think that a few sensible people would stumble across these threads and say to himself, wow, Biotransplant really is a bargain, and grab a few shares. And yet, nobody but a few biofreaks and one or two hangers-on (myself) seem to frequent the threads. A little discouraging. The only conclusion I can come to is keep a lot of powder dry, and hold some shares in each of the top ten you find. I've seen CORR suggested by Jubak of MS investor, McCamant, RCMac here on SI, and as a Value Line biotech pick for the year. Wow.